• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物致幻剂亚甲二氧基甲基苯丙胺( ayahuasca )的治疗作用的分子途径,一种潜在的快速抗抑郁药。

Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.

机构信息

Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14040-900, Brazil.

National Institute of Science and Technology-Translational Medicine, Ribeirão Preto 3900, Brazil.

出版信息

Biomolecules. 2022 Nov 2;12(11):1618. doi: 10.3390/biom12111618.

DOI:10.3390/biom12111618
PMID:36358968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9687782/
Abstract

Ayahuasca is a psychoactive brew traditionally used in indigenous and religious rituals and ceremonies in South America for its therapeutic, psychedelic, and entheogenic effects. It is usually prepared by lengthy boiling of the leaves of the bush and the mashed stalks of the vine in water. The former contains the classical psychedelic N,N-dimethyltryptamine (DMT), which is thought to be the main psychoactive alkaloid present in the brew. The latter serves as a source for β-carbolines, known for their monoamine oxidase-inhibiting (MAOI) properties. Recent preliminary research has provided encouraging results investigating ayahuasca's therapeutic potential, especially regarding its antidepressant effects. On a molecular level, pre-clinical and clinical evidence points to a complex pharmacological profile conveyed by the brew, including modulation of serotoninergic, glutamatergic, dopaminergic, and endocannabinoid systems. Its substances also interact with the vesicular monoamine transporter (VMAT), trace amine-associated receptor 1 (TAAR1), and sigma-1 receptors. Furthermore, ayahuasca's components also seem to modulate levels of inflammatory and neurotrophic factors beneficially. On a biological level, this translates into neuroprotective and neuroplastic effects. Here we review the current knowledge regarding these molecular interactions and how they relate to the possible antidepressant effects ayahuasca seems to produce.

摘要

阿育吠陀是一种精神活性的酿造物,传统上在南美洲被用于土著和宗教仪式和典礼中,因其治疗、迷幻和致幻效果而受到重视。它通常通过长时间煮沸灌木的叶子和藤本植物的捣碎茎干在水中制成。前者含有经典的迷幻 N,N-二甲基色胺(DMT),被认为是这种酿造物中主要的精神活性生物碱。后者是β-咔啉的来源,β-咔啉以其单胺氧化酶抑制(MAOI)特性而闻名。最近的初步研究提供了令人鼓舞的结果,调查了阿育吠陀的治疗潜力,特别是其抗抑郁作用。在分子水平上,临床前和临床证据表明,这种酿造物具有复杂的药理学特征,包括对 5-羟色胺能、谷氨酸能、多巴胺能和内源性大麻素系统的调节。其物质还与囊泡单胺转运蛋白(VMAT)、痕量胺相关受体 1(TAAR1)和西格玛-1 受体相互作用。此外,阿育吠陀的成分似乎还能调节有益的炎症和神经营养因子的水平。在生物学水平上,这转化为神经保护和神经可塑性的作用。在这里,我们回顾了这些分子相互作用的现有知识,以及它们与阿育吠陀似乎产生的可能的抗抑郁作用之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005d/9687782/888785a0d012/biomolecules-12-01618-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005d/9687782/888785a0d012/biomolecules-12-01618-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005d/9687782/888785a0d012/biomolecules-12-01618-g001.jpg

相似文献

1
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.植物致幻剂亚甲二氧基甲基苯丙胺( ayahuasca )的治疗作用的分子途径,一种潜在的快速抗抑郁药。
Biomolecules. 2022 Nov 2;12(11):1618. doi: 10.3390/biom12111618.
2
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.阿育吠陀:心理和生理效应、药理学以及在成瘾和精神疾病中的潜在用途。
Curr Neuropharmacol. 2019;17(2):108-128. doi: 10.2174/1570159X16666180125095902.
3
Ayahuasca for the Treatment of Depression.用阿育吠陀治疗抑郁症。
Curr Top Behav Neurosci. 2022;56:113-124. doi: 10.1007/7854_2021_277.
4
Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.阿亚瓦斯卡化合物对寄生虫血症的免疫调节与控制:恰加斯病的治疗潜力
Chem Biodivers. 2022 Oct;19(10):e202200409. doi: 10.1002/cbdv.202200409. Epub 2022 Sep 26.
5
: An ancient sacrament for treatment of contemporary psychiatric illness?一种用于治疗当代精神疾病的古老圣礼?
Ment Health Clin. 2018 Mar 23;7(1):39-45. doi: 10.9740/mhc.2017.01.039. eCollection 2017 Jan.
6
Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.口服宗教背景下的阿育吠陀后唾液和血清中 N,N-二甲基色胺和β-咔啉的动力学特征。
Drug Test Anal. 2021 Mar;13(3):664-678. doi: 10.1002/dta.2955. Epub 2020 Nov 3.
7
Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.阿亚瓦西卡暴露情况:2005年至2015年美国中毒控制中心接到的相关电话描述性分析
J Med Toxicol. 2017 Sep;13(3):245-248. doi: 10.1007/s13181-016-0593-1. Epub 2016 Nov 28.
8
Ayahuasca: Pharmacology, neuroscience and therapeutic potential.阿亚瓦斯卡:药理学、神经科学与治疗潜力。
Brain Res Bull. 2016 Sep;126(Pt 1):89-101. doi: 10.1016/j.brainresbull.2016.03.002. Epub 2016 Mar 11.
9
Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.迷幻疗法:初级保健临床医生指南-N,N-二甲基色胺和瓜拉那。
Am J Ther. 2024;31(2):e112-e120. doi: 10.1097/MJT.0000000000001725.
10
Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.南美洲致幻植物中的单胺氧化酶抑制剂:死藤水的色胺和β-咔啉成分。
J Ethnopharmacol. 1984 Apr;10(2):195-223. doi: 10.1016/0378-8741(84)90003-5.

引用本文的文献

1
Ayahuasca partially preserves striatal integrity in juvenile non-human primates exposed to chronic stress: evidence from stereological evaluation.在暴露于慢性应激的幼年非人灵长类动物中,阿亚瓦斯卡部分保留了纹状体的完整性:来自体视学评估的证据。
Front Neuroanat. 2025 Feb 19;19:1457557. doi: 10.3389/fnana.2025.1457557. eCollection 2025.
2
Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics.为什么N,N-二甲基色胺很重要:超越传统迷幻剂的独特特征和治疗潜力。
Front Psychiatry. 2024 Nov 6;15:1485337. doi: 10.3389/fpsyt.2024.1485337. eCollection 2024.
3
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.

本文引用的文献

1
Synaptic plasticity as a therapeutic target to modulate circuits in psychiatric disorders.作为调节精神疾病中神经回路的治疗靶点的突触可塑性
Neuropsychopharmacology. 2023 Jan;48(1):1-2. doi: 10.1038/s41386-022-01458-3. Epub 2022 Sep 27.
2
Towards an understanding of psychedelic-induced neuroplasticity.迈向对迷幻剂引起的神经可塑性的理解。
Neuropsychopharmacology. 2023 Jan;48(1):104-112. doi: 10.1038/s41386-022-01389-z. Epub 2022 Sep 19.
3
Antidepressant and anxiolytic-like effects of ayahuasca in rats subjected to LPS-induced neuroinflammation.
神经生物学对 N,N-二甲基色胺(DMT)及其单胺氧化酶(MAO)抑制作用的研究:从雅砻酒到 DMT 和 MAO 抑制剂的合成组合。
Cell Mol Life Sci. 2024 Sep 10;81(1):395. doi: 10.1007/s00018-024-05353-6.
4
The Effects of Ayahuasca on Psychological Disorders: A Systematic Literature Review.死藤水对心理障碍的影响:一项系统文献综述。
Cureus. 2024 Mar 5;16(3):e55574. doi: 10.7759/cureus.55574. eCollection 2024 Mar.
5
Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the "God Molecule".对关于二甲基色胺和“上帝分子”的系统评价文献的信息监测与批判性分析。
Pharmaceuticals (Basel). 2023 Jun 2;16(6):831. doi: 10.3390/ph16060831.
6
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.迷幻剂的光明面:神经药理学的最新进展与挑战。
Int J Mol Sci. 2023 Jan 10;24(2):1329. doi: 10.3390/ijms24021329.
LPS 诱导的神经炎症大鼠中,ayahuasca 的抗抑郁和抗焦虑样作用。
Behav Brain Res. 2022 Sep 26;434:114007. doi: 10.1016/j.bbr.2022.114007. Epub 2022 Jul 14.
4
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials.氯胺酮和经典致幻剂对单相难治性抑郁症中神经营养和炎症标志物的影响:一项临床试验的系统评价
Eur Arch Psychiatry Clin Neurosci. 2023 Feb;273(1):129-155. doi: 10.1007/s00406-022-01460-2. Epub 2022 Jul 13.
5
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.基于血液的抗抑郁药反应生物标志物:氯胺酮和 Esketamine 的系统评价和荟萃分析。
Mol Psychiatry. 2022 Sep;27(9):3658-3669. doi: 10.1038/s41380-022-01652-1. Epub 2022 Jun 27.
6
Sustained effects of single doses of classical psychedelics in humans.人类单次摄入经典迷幻药的持续效应。
Neuropsychopharmacology. 2023 Jan;48(1):145-150. doi: 10.1038/s41386-022-01361-x. Epub 2022 Jun 21.
7
Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate.哺乳动物 N, N-二甲基色胺 (DMT) 的意义:一场长达 60 年的争论。
J Psychopharmacol. 2022 Aug;36(8):905-919. doi: 10.1177/02698811221104054. Epub 2022 Jun 13.
8
Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder.探索性研究二甲基色胺(DMT)在健康志愿者和重度抑郁症患者中的剂量相关安全性、耐受性和疗效。
Neuropsychopharmacology. 2022 Sep;47(10):1854-1862. doi: 10.1038/s41386-022-01344-y. Epub 2022 Jun 3.
9
Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands.死藤水与公共卫生II:荷兰大量死藤水仪式参与者的健康状况
J Psychoactive Drugs. 2023 Jul-Aug;55(3):247-258. doi: 10.1080/02791072.2022.2077155. Epub 2022 May 28.
10
Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field.反复给予安非他命对暴露于开阔场的雄性大鼠行为和 c-Fos 表达的影响。
Behav Brain Res. 2022 Jun 3;427:113878. doi: 10.1016/j.bbr.2022.113878. Epub 2022 Apr 1.